Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide widely distributed in the central nervous system (CNS) and many peripheral organs, such as the digestive tract, endocrine, reproductive and respiratory systems, where it plays different regulatory functions and exerts a cytoprotective effect. The multifarious physiological effects of PACAP are mediated through binding to different G protein-coupled receptors, including PAC1 (PAC1-R), VPAC1 (VPAC1-R) and VPAC2 (VPAC2-R) receptors. In the gastrointestinal (GI) tract, PACAP plays an important regulatory function. PACAP stimulates the secretion of digestive juices and hormone release, regulates smooth muscle contraction, local blood flow, cell migration and proliferation. Additionally, there are many reports confirming the involvement of PACAP in pathological processes within the GI tract, including inflammatory states, neuronal injury, diabetes, intoxication and neoplastic processes. The purpose of this review is to summarize the distribution and pleiotropic action of PACAP in the control of GI tract function and its cytoprotective effect in the course of GI tract disorders.

Highlights

  • Numerous morphological and neurochemical studies indicated that Pituitary adenylate cyclase-activating polypeptide (PACAP) is widely distributed in the GI tract of numerous species, including humans

  • PACAP participates in many physiological functions in the digestive tract, such as regulation of motility, the secretion of digestive juices, exocrine function of the pancreas, intestinal absorption, cell migration and proliferation

  • An increasing number of scientific reports have confirmed that PACAP is an important cytoprotective factor with anti-apoptotic, antiinflammatory and antioxidant properties

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide that was first identified in an ovine hypothalamus extract in 1989 It is involved in stimulating adenylate cyclase from cultured rat pituitary cells [1]. 2. Localization of PACAP in the Gastrointestinal Tract in Individual Species of Mammals. The presence of PACAP in the GI tract has been described in various mammal species, including humans [7,10,11,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33].

Rodents
Humans
Other Species
Co-Localization of PACAP with Other Neuroactive Substance in the GI Tract
PACAP Receptors and Their Localization in the GI Tract
Physiological Role of PACAP in the GI Tract
PACAP Participation in Pathological Processes in the GI Tract
Inflammatory Condition
Injuries and Intoxications
Neoplastic Processes
Other Disorders of the GI Tract
Therapeutic Use of PACAP and Its Receptors Agonists
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.